Catapult Therapeutics is a privately held Dutch biotech company developing CAP-100 – an innovative first-in-class humanized anti-CCR7 antibody.
Company Details
- Address
- 's-Hertogenbosch, Nl
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Stadtkreis 6.
- HQ
- 's-Hertogenbosch
Catapult Therapeutics Questions
Catapult Therapeutics's website is https://www.catapult-therapeutics.com/
Catapult Therapeutics's LinkedIn profile is https://nl.linkedin.com/company/catapulttherapeutics
Catapult Therapeutics's industry is
Biotechnology Research
Catapult Therapeutics's top competitors are
Biomay Ag,
Brim Biotechnology, Inc.,
Cristal Therapeutics,
Life Science Cares Switzerland,
Hybridize Therapeutics,
Cimaas Bv,
Kynexis,
Ntrans Technologies Bv,
Zylem Biosciences,
Molecular Partners.
Catapult Therapeutics's categories are Biotechnology Research
